Oct 03, 2011, 05.43 PM | Source: CNBC-TV18
Pharma major Wockhardt now has additional time on its hands to finalise a formal repayment plan for its overseas bond holders.
The company has total dues of Rs 358 crore it was supposed to revert to the Bombay High Court with a detailed plan by October 3.
It now has extra time as the court today adjourned the case to October 11.
A group of bondholders led by the bond trustee of the Bank of New York Mellon, Sun Pharma Global and hedge fund QVT besides some creditors had taken Wockhardt to court, filing a wind-up petition, after the company defaulted on repayment of its USD 110-million FCCBs, in 2009.
Wockhardt stock price
On April 29, 2016, Wockhardt closed at Rs 994.40, down Rs 3, or 0.3 percent. The 52-week high of the share was Rs 1748.20 and the 52-week low was Rs 706.35.
The company's trailing 12-month (TTM) EPS was at Rs 1.09 per share as per the quarter ended December 2015. The stock's price-to-earnings (P/E) ratio was 912.29. The latest book value of the company is Rs 96.98 per share. At current value, the price-to-book value of the company is 10.25.
In an interview with CNBC-TV18, market analyst SP
VK Sharma of HDFC Securities recommends buying Woc
Rajat Bose of rajatkbose.com is of the view that W
Manas Jaiswal of manasjaiswal.com is of the view t
Gaurav Bissa of LKP Securities recommends going lo
Ashwani Gujral of ashwanigujral.com is of the view
The Delhi High Court sought AAP government's respo
Bombay Rayon Fashions Ltd has informed BSE that an